Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-24T16:36:10.761Z Has data issue: false hasContentIssue false
  • English
  • Français

Consumerism for Neurobiological Disorders: An Assessment

Published online by Cambridge University Press:  10 March 2009

Richard E. Peschel  and
Enid Peschel
Richard E. Peschel
Affiliation:
Yale University School of Medicine
Enid Peschel
Affiliation:
Yale University School of Medicine
Get access Rights & Permissions [Opens in a new window]

Abstract

Consumerism is a growing phenomenon in U.S. health care, yet its exercise is still inhibited by powerful forces within the medical community. Despite the neuroscientific framework that stresses the commonalities between mental and physical illness, consumerism is even more problematic and difficult in mental health care than in other areas of health care. People with severe mental illness and their advocates must contend with limited public understanding of neurobiological disorders, poor definitions of effective treatment, and a paucity of outcome data, especially from prospective randomized and long-term studies. The only clear way for consumerism to grow in mental health care is for its advocates to align themselves with the neuroscientific revolution and to demand that effective and equitable treatment programs be created based on the documented evidence of the physical nature of neurobiological disorders.

Type
Special Section: The Assessment of Psychiatry
Information
International Journal of Technology Assessment in Health Care , Volume 12 , Issue 4 , Fall 1996 , pp. 644 - 656
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Brotman, A. W., Falk, W. E., & Gelenberg, A. J. Pharmacologic treatment of acute depressive subtypes. In Meltzer, H. Y. (ed.), Psychopharmacology: The third generation of progress, New York: Raven Press, 1987, 1031–40.Google Scholar
2.Califano, J. A.America's health care revolution: Who lives? Who dies? Who pays? New York: Random House, 1986.Google ScholarPubMed
3.Charman, R. C.At Risk: Can the doctor-patient relationship survive in a high-tech world? Dublin, NH: William L. Bauhan, 1992, 167.Google Scholar
4.Cockerman, W. C. The changing pattern of physician-patient interaction. In Clair, J. M. & Allman, R. M. (eds.), Sociomedical perspectives on patient care. Lexington, KY: University of Kentucky Press, 1993, 47–57.Google Scholar
5.Crick, F.The astonishing hypothesis: The scientific search for the soul. New York: Charles Scribner's Sons, 1994.Google Scholar
6.De Bruyn, A., Mendelbaum, K., Sandkuijl, L. A., et al. Nonlinkage of bipolar illness to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11. American Journal of Psychiatry, 1994, 151, 102–06.Google ScholarPubMed
7.Dyer, A. R.Self-psychology as an avenue to pre-Oedipal experience. Psychiatric Quarterly, 1994, 65, 3.CrossRefGoogle ScholarPubMed
8.Gerteis, M., Edgman-Levitan, S., Daley, J., & Delbanco, T. L., (eds.), Through the patient's eyes: Understanding and promoting patient-centered care. San Francisco: Jossey-Bass, 1993, 207.Google Scholar
9.Goldman, E. B. Legal requirements of informed consent for treatment of breast cancer: Telling it all. In Harness, J. K., Oberman, H. A., Lichter, A. S., Adler, D. D., & Cody, R. L. (eds.), Breast cancer: Collaborative management. Chelsea, MI: Lewis Publishers, Inc., 1988, 41–54.Google Scholar
10.Grosch, W. N.Narcissism: Shame, rage, and addiction. Psychiatric Quarterly, 1994, 65, 49.CrossRefGoogle ScholarPubMed
11. H. R. 1703: Equitable Health Care for Neurobiological Disorders Act, 103D Congress, 1st Session, 04 7, 1993.Google Scholar
12.Habuchi, T., Ogawa, O., Kakehi, Y., et al. Accumulated allelic losses in the development of invasive urothelial cancer. International Journal of Cancer, 1993, 53, 579.CrossRefGoogle ScholarPubMed
13.Hashimoto, T., Kitamura, N., Kajimoto, Y., et al. Differential changes in serotonin 5-HT1A and 5-HT2 receptor building in patients with chronic schizophrenia. Psychopharmacology, 1993, 112, 535.CrossRefGoogle Scholar
14.Klein, R. G. Pharmacotherapy of childhood hyperactivity: An update. In Meltzer, H. Y. (ed.), Psychopharmacology: The third generation of progress. New York: Raven Press, 1987, 1215–24.Google Scholar
15.Klerman, G. L.The psychiatric patient's right to effective treatment: Implication of Osheroff v. Chestnut Lodge. American Journal of Psychiatry, 1990, 147, 409.Google ScholarPubMed
16.Lazovich, D., White, E., Thomas, D. B., & Moe, R. E.Underutilization of breast conserving surgery and radiation therapy among women with stage I or II breast cancer. Journal of the American Medical Association, 1991, 24, 3433.CrossRefGoogle Scholar
17.Lu-Yao, G. I., & Greenberg, E. R.Changes in prostate cancer incidence and treatment in USA. Lancet, 1994, 343, 251.Google Scholar
18.Meltzer, H. Y. (ed.), Psychopharmacology: The third generation of progress. New York: Raven Press, 1987.Google Scholar
19.Merikangas, J. R. Headache syndromes. In Stoudemire, A. & Fogel, B. S. (eds.), Medical psychiatric practice, vol. I. Washington, DC: American Psychiatric Press, 1991, 393–424.Google Scholar
20.Michels, R., & Marzuk, P. M.Progress in psychiatry (first of two parts). New England Journal of Medicine, 1993, 329, 552–60.CrossRefGoogle Scholar
22.Ohsfeldt, R. L. Contractual arrangements, financial incentives, and physician-patient relationships. In Clair, J. M. & Allman, R. M. (eds.), Sociomedical perspectives on patient care. Lexington, KY: University of Kentucky Press, 1993, 96–113.Google Scholar
23.O'Keefe, A. M. Reforming insurance law to provide equitable coverage for persons with neurobiological disorders. In Peschel, E., Peschel, R., Howe, C. W., & Howe, J. W. (eds.), Neurobiological disorders in children and adolescents. San Francisco: Jossey-Bass, 1992, 101–05.Google Scholar
21.Michels, R., & Marzuk, P. M.Progress in psychiatry (second of two parts). New England Journal of Medicine, 1993, 329, 628–38.CrossRefGoogle Scholar
24.Peschel, R. E., & Peschel, E.Prospective, retrospective, and anecdotal data: A demand for science in child psychiatry. NAMI CAN News, 1991, 1,1.Google Scholar
25.Peschel, R., & Peschel, E. Selective empathy. In Spiro, H., Curnen, M. G. M., Peschel, E., & St. James, D. (eds.), Empathy and the practice of medicine. New Haven, CT: Yale University Press, 1993, 110–20.Google Scholar
26.Peschel, E., Peschel, R. E., Howe, C. W. & Howe, J. W. (eds.), Neurobiological disorders in children and adolescents. San Francisco: Jossey-Bass, 1992.Google Scholar
27.Peschel, R. E., Wilson, L., Haffty, B. et al. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. International Journal of Radiation Oncology, Biology, and Physics, 1993, 26, 539–44.CrossRefGoogle ScholarPubMed
28.Polednak, A. P., & Flannery, J. T.Trends in breast cancer treatment in Connecticut. Connecticut Medicine, 1993, 57, 59–64.Google Scholar
29.Recht, A., & Harris, J. R. Conservative surgery and radiation therapy for early breast cancer. In Devita, V. T., Hellman, S., & Rosenberg, S. (eds.), Cancer: Principles and practice of oncology—Updates, vol. 1. Philadelphia: JB Lippincott, 1987, 1–12.Google Scholar
30.Robbins, M.Experiences of schizophrenia. New York: Guilford Press, 1993.Google Scholar
31.Rodwin, M. A.Medicine, money, & morals: Physicians’ conflicts of interest. New York: Oxford University Press, 1993.Google Scholar
32.Satariano, E. R., Swanson, G. M., & Moll, P. P. Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. American Journal of Public Health, 1992, 82, 195–98.Google Scholar
33.Schain, W. S.Patients’ rights in decision making: The case for personalism versus pater nalism in health care. Cancer, 1980, 46, 1035–41.Google Scholar
34.Sidransky, D., & Messing, E.Molecular genetics and biochemical mechanisms in bladder cancer. Urologic Clinics of North America, 1992, 19, 629–39.CrossRefGoogle ScholarPubMed
35.Torrey, E. F.Nowhere to go: The tragic odyssey of the homeless mentally ill. New York: Harper & Row, 1988.Google Scholar
36.Torrey, E. F.Freudian fraud: The malignant effect of Freud’s theory on American thought and culture. New York: Harper Collins, 1992.Google Scholar
37.Torrey, E. F., Erdman, K., Wolfe, S. M., & Flynn, L. M.Care of the seriously mentally ill: A rating of state programs. Washington, DC: Public Citizen Health Research Group and the National Alliance, for the Mentally III, 1990.Google Scholar
38.U.S. Congress, Office of Technology Assessment. The biology of mental disorders: New developments in neuroscience. Washington DC: U.S. Government Printing Office, 1992.Google Scholar
39.Weinberg, R. A.Tumor suppressor genes. Science, 1991, 254, 1138–46.Google Scholar
40.Wyatt, R. J. NeuroleptJcs and the natural course of schizophrenia. In Kane, J. M. (ed.), New developments in Ike pharmacologic treatment of schizophrenia. Washington, DC: National Institutes of Mental Health, U.S. Department of Health and Human Services, 1993, 133–63.Google Scholar